News Public trusts supermarkets more than pharma - poll Swiss company looks move on from Tamiflu scandal
Brexit Pharma and biotech warn of Brexit threat to science recruitm... Government must strike science R&D deal with EU, says ABPI
News J&J speaks out as old drug included in lethal injection State of Florida to use untried cocktail in execution of Mark Asay
News Pharma welcomes UK's post-Brexit trade plans UK pharma and biotech trade bodies have welcomed government proposals to ensure trade and services can continue after Brexit in March 2019.
News Trump disowns health reforms, will 'let Obamacare fail' President may have to work with Democrats to reform healthcare system
News UK ministers seek a soft Brexit for pharma Health and business secretaries commit to close working with EMA
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
